Search - tctmd.com

Displaying 1 - 20 of 77

Sort: Relevancy | Date

Presentation TCT 2024

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Presenter: Jerry Lipinski

October 30, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

Presentation TCT 2024

The Role of Cerebral Embolic Protection in TAVR

Presenter: Samir Kapadia

October 28, 2024

Presentation TCT 2024

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

Presenter: Han Su Park

October 27, 2024

Presentation NY Valves 2024

First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR

Presenter: Tamim M. Nazif

June 07, 2024

Presentation NY Valves 2024

The Promise of Next Generation Cerebral Embolic Protection Devices

Presenter: Tamim M. Nazif

June 05, 2024

Presentation NY Valves 2024

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Presenter: Alexandra J. Lansky

June 05, 2024

Presentation NY Valves 2024

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Presentation TCT 2023

TCT 213: Effectiveness of Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement with High Aortic Valve Calcium Burden

Presenter: Ofir Koren

October 25, 2023

Presentation TCT 2023

TCT 483: Patients With Previous Cerebrovascular Events Undergoing Transcatheter Aortic Valve Implantation Have More Periprocedural Strokes

Presenter: Astrid van Nieuwkerk

October 25, 2023

Presentation TCT 2023

TCT 465: PROTEMBO C-TRIAL: Evaluation of a Novel Cerebral Embolic Protection Device in TAVR

Presenter: Darren Mylotte

October 25, 2023

Presentation TCT 2023

TCT 412: Geometric Predictors of Stroke After Transcatheter Aortic Valve Replacement

Presenter: Brennan Vogl

October 25, 2023

Presentation TCT 2023

TCT 181: Bovine Arch is Associated with Higher Incidence of Stroke after TAVR

Presenter: Gerardo V. Lo Russo

October 25, 2023

Presentation TCT 2023

TCT 94: ProtEmbo: A Potential Shield Against Stroke and Cerebral Lesions in TAVR; Illustrated Using DW-MRI to Assess Device Efficacy

Presenter: Tobias Schmidt

October 25, 2023

Presentation TVT 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presenter: Tamim Nazif

June 07, 2023

Presentation TCT 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Presenter: Alexandra J. Lansky

September 17, 2022

Presentation TCT 2022

New and Novel CEP Devices: Differentiating Features

Presenter: Giora Weisz

September 17, 2022

Presentation TCT 2022

The British Heart Foundation PROTECT TAVI Trial: The Next Round!

Presenter: Daniel J. Blackman

September 17, 2022

Presentation TCT 2022

Other Registry Findings and PROTECTED TAVR: Concordant or Divergent

Presenter: Raj Makkar

September 17, 2022

Advertisement

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

The Role of Cerebral Embolic Protection in TAVR

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR

The Promise of Next Generation Cerebral Embolic Protection Devices

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

TCT 213: Effectiveness of Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement with High Aortic Valve Calcium Burden

TCT 483: Patients With Previous Cerebrovascular Events Undergoing Transcatheter Aortic Valve Implantation Have More Periprocedural Strokes

TCT 465: PROTEMBO C-TRIAL: Evaluation of a Novel Cerebral Embolic Protection Device in TAVR

TCT 412: Geometric Predictors of Stroke After Transcatheter Aortic Valve Replacement

TCT 181: Bovine Arch is Associated with Higher Incidence of Stroke after TAVR

TCT 94: ProtEmbo: A Potential Shield Against Stroke and Cerebral Lesions in TAVR; Illustrated Using DW-MRI to Assess Device Efficacy

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

New and Novel CEP Devices: Differentiating Features

The British Heart Foundation PROTECT TAVI Trial: The Next Round!

Other Registry Findings and PROTECTED TAVR: Concordant or Divergent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content